Dashboard › CL1: Health › Key Facts
HORIZON-HLTH-2026-01-STAYHLTH-03

Building public trust and outreach in the life sciences

CSA Cluster 1 €1,900,000 16 Apr 2026
Topic Code HORIZON-HLTH-2026-01-STAYHLTH-03 F&T Portal
Call Identifier HORIZON-HLTH-2026-01 Call 01 — single stage (2026)
Instrument HORIZON-CSA Coordination and Support Action
Budget Model Lump Sum HORIZON-AG-LS
Funding Rate 100% Annex G — CSA = 100%
Page Limit (Part B) 28 pages CSA + lump sum (Annex A)
Evaluation Thresholds 4 / 4 / 4 · cum. 12 Non-standard — topic override
Expected Projects 1 €1.5–1.9M per project (WP stated)
Destination Staying healthy in a rapidly changing society WP Part 4
Cluster / Pillar Cluster 1 / Pillar II Health
China Eligibility Eligible ✓ CSA not restricted (RIA/IA only)
Special Conditions Coordinator: EU/AC only Coordinator must be from MS or AC
Verify: Open this topic on the F&T Portal →  ·  Sources: General Annexes 2026-2027, WP Part 4
See what a full Decision Brief looks like →
Compliance traps · Scoring playbook · Consortium blueprint · 2 free examples available
China is eligible for this topic. The destination’s China restriction applies to RIA and IA only — CSA is not restricted.
This topic uses non-standard evaluation thresholds: 4 (Excellence) / 4 (Impact) / 4 (Implementation), cumulative 12. Standard thresholds are 3/3/3 cumulative 10.
US entities eligible: In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America are eligible to receive Union funding under this topic.
Copernicus/Galileo: If the project uses satellite-based earth observation, positioning, navigation and/or related timing data, beneficiaries must make use of Copernicus and/or Galileo/EGNOS.

Expected Outcomes

  1. Strengthened capacity of life sciences actors in science communication, risk communication, public outreach, and citizen engagement.
  2. Strengthened awareness of risks and benefits of life sciences by the public, by showcasing the latest Research and Innovation (R&I) developments in the life sciences, and their societal impact.
  3. New and innovative approaches developed to engage the public in R&I activities in the life sciences, with an emphasis on inclusive and participatory approaches, involving relevant stakeholders (e.g. researchers, research funders, policymakers, publishers, civil society organisations, business, and citizens).

Want the full analysis?

The key facts above tell you WHAT. The full Decision Brief tells you HOW to win.

Compliance traps Scoring playbook Consortium blueprint Positioning guide Red flags Quick-start checklist
Order Full Brief — €79
Delivered within 1 working day
Disclaimer: This page is produced using advanced AI analysis and reviewed by an experienced EU grant engineer. While we take care to ensure accuracy, the information may contain errors or become outdated. It is the applicant’s sole responsibility to verify all facts against the official EU Funding & Tenders Portal before making any decisions. Global Disruption accepts no liability for errors, omissions, or decisions made based on this content. No refunds are offered for Key Facts pages or Decision Briefs.